Construction of a plasmid coding for green fluorescent protein tagged cathepsin L and data on expression in colorectal carcinoma cells  by Tamhane, Tripti et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 5 (2015) 468–475http://d
2352-34
(http://c
DOI
n Corr
E-m
1 Prjournal homepage: www.elsevier.com/locate/dibData ArticleConstruction of a plasmid coding for green
ﬂuorescent protein tagged cathepsin L and data
on expression in colorectal carcinoma cells
Tripti Tamhane a, Brit K. Wolters a, Rukshala Illukkumbura a,1,
Gunhild M. Maelandsmo b, Mads H. Haugen a,b, Klaudia Brix a,n
a Department of Life Sciences and Chemistry, Jacobs University Bremen, Campus Ring 1, D-28759 Bremen,
Germany
b Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital – The Norwegian
Radium Hospital, Oslo, Norwaya r t i c l e i n f o
Article history:
Received 4 September 2015
Received in revised form
18 September 2015
Accepted 18 September 2015
Available online 30 September 2015
Keywords:
Cysteine cathepsin L
Green ﬂuorescent protein
Colorectal carcinomax.doi.org/10.1016/j.dib.2015.09.022
09/& 2015 The Authors. Published by Else
reativecommons.org/licenses/by/4.0/).
of original article: http://dx.doi.org/10.1016
esponding author.
ail address: k.brix@jacobs-university.de (K.
esent address: EMBL, Meyerhofstrasse 1, 6a b s t r a c t
The endo-lysosomal cysteine cathepsin L has recently been shown
to have moonlighting activities in that its unexpected nuclear
localization in colorectal carcinoma cells is involved in cell cycle
progression (Tamhane et al., 2015) [1]. Here, we show data on the
construction and sequence of a plasmid coding for human cathe-
psin L tagged with an enhanced green ﬂuorescent protein (phCL-
EGFP) in which the ﬂuorescent protein is covalently attached to the
C-terminus of the protease. The plasmid was used for transfection
of HCT116 colorectal carcinoma cells, while data from non-
transfected and pEGFP-N1-transfected cells is also shown. Immu-
noblotting data of lysates from non-transfected controls and
HCT116 cells transfected with pEGFP-N1 and phCL-EGFP, showed
stable expression of cathepsin L-enhanced green ﬂuorescent pro-
tein chimeras, while endogenous cathepsin L protein amounts
exceed those of hCL-EGFP chimeras. An effect of phCL-EGFP
expression on proliferation and metabolic states of HCT116 cells
at 24 h post-transfection was observed.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.biochi.2015.09.003
Brix).
9117 Heidelberg, Germany.
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Dubject area Molecular cell biology
ore speciﬁc sub-
ject areaCathepsin L protease mis-trafﬁcking to the nucleus of colorectal cancer cellsype of data Plasmid sequence data, vector map, graph, ﬁgure
ow data was
acquiredIsolation of cathepsin L mRNA from HaCaT cells, reverse transcription to
cDNA and vector construction by insertion into pEGFP-N1 (Clontech) using
restriction sites NheI and BamHI, transfection of HCT116 colorectal carcinoma
cells (ATCC) through X-treme GENE HP DNA transfection reagent (Roche
Diagnostics), quantitation of cell proliferation rates and metabolic activity by
MTT conversion assays, SDS-PAGE of whole cell lysates and immunoblotting
with anti-cathepsin L antibodies and chemi-luminescence detectionata format Analyzed
xperimental
factorsCells transfected with two different plasmids were used in comparison with
non-transfected controlsxperimental
featuresProliferation and metabolic activity of transfected and non-transfected cells
were quantiﬁed, and the molecular mass of expressed hCL-EGFP protein was
determined in whole cell lysates by SDS-PAGE and immunoblotting.ata source
locationBremen, Germanyata accessibility Data is provided in the articleD
Value of the data
 This article provides information on the construction of a vector coding for human cathepsin L-
EGFP chimeras, and it describes the insert's sequence.
 The data provide detailed information on the molecular forms of cathepsin L chimeras with
enhanced green ﬂuorescent protein that are expressed in the human colorectal carcinoma HCT116
cell line.
 The article provides data on the effects of cathepsin L-EGFP expression in HCT116 cells with regard
to proliferation rates and metabolic activity.
Data
EGFP-tagging is used to visualize transport and trafﬁcking of cellular proteins including cysteine
cathepsin proteases [2]. We have shown that EGFP-tagging does not interfere with intrinsic sorting
signals at the N-terminus of cysteine cathepsin proteases when the tag is attached to the C-terminus
via a spacer peptide [2–4]. In addition, transport to endo-lysosomal compartments and other cellular
destinations is not affected by the EGFP tag [2–4]. Likewise, proteolytic activity is pertained in
cathepsin-EGFP chimeras expressed in mammalian cell lines [2–7].
We have shown that cathepsin L is sorted and mis-trafﬁcked to the nucleus of HCT116 cells as full-
length protein and in proteolytically active form [1]. More speciﬁcally, nuclear cathepsin L accelerates
cell cycle progression of HCT116 cells which are hyper-proliferative colorectal carcinoma cells. In this
article, we demonstrate via expression of cathepsin L-EGFP chimeras the effects of enhanced protease
expression promoting proliferation of HCT116 cells.1. Experimental design, materials and methods
In this article, we describe the construction of a vector encoding human cathepsin L-EGFP (hCL-
EGFP) with cDNA derived from cathepsin L mRNA of human HaCaT keratinocytes upon insertion into
the multiple cloning site of pEGFP-N1 by NheI and BamHI restriction. Here, we share the relevant
sequence data of phCL-EGFP. The vector is introduced through lipofection to express chimeric, EGFP-
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regard to proliferation and metabolic activity by MTT-assays upon transfection with phCL-EGFP in
comparison to non-transfected and pEGFP-N1-transfected cells. The molecular forms of protein chi-
meras expressed in HCT116 cells were identiﬁed by immunoblotting of whole cell lysates separated
by SDS-PAGE.
1.1. RNA preparation from HaCaT cells
The human keratinocyte line HaCaT (Human adult low Calcium high Temperature) was provided
by Prof. Dr. Petra Boukamp (Deutsches Krebsforschungszentrum DKFZ, Heidelberg, Germany) and
cultured in Dulbecco's modiﬁed Eagle's Medium (DMEM; Cambrex Corp., Verviers, Belgium) sup-
plemented with 10% fetal calf serum (FCS; Gibco™ Invitrogen GmbH, Karlsruhe, Germany). Total RNA
was isolated from phosphate-buffered saline (PBS)-washed conﬂuent HaCaT cell cultures using TRI-
ZOL reagent (TRIZOL; Invitrogen, Karlsruhe, Germany) with subsequent chloroform and isopropanol
puriﬁcation. The RNA pellet was washed with 75% ethanol and ﬁnally re-suspended in 30 ml of DEPC-
treated water (Ambion, Huntigdon, UK). The RNA concentration was determined by nanodrop
microphotometry (Kisker, Steinfurt, Germany) before aliquots were either directly used or snap-
frozen in liquid nitrogen and stored at 80 °C.1.2. Vector construction
Total RNA at a concentration of 0.05 mg/mL was reverse transcribed with a cDNA cycle kit (Invi-
trogen, Karlsruhe, Germany) using oligo dT primers and AMV reverse transcriptase. Ampliﬁcation of
the complete cathepsin L coding sequence was by PCR with 500 ng cDNA using 0.5 mM each of the
primers “CL for NheI” (50-aca cag gtt tta aaa cat gaa tcc tac a-30) and “CL rev BamHI” (50-agc tac ccc act
gtg tga gct ggt gga-30), 0.125 mM each of dNTPs, and 0.4 U Phusion DNA polymerase (Finnzymes,
Espoo, Finland). By this cloning strategy, restriction sites for NheI and BamHI were introduced and the
stop codon was removed, thus eventually yielding the sequence for a chimeric protein with the full-
length cathepsin L sequence covalently connected to the EGFP tag by a spacer peptide linker. The ﬁnal
PCR product and pEGFP-N1 plasmid were each digested with NheI and BamHI (both, MBI, St. Leon-Rot,
Germany). The restricted cDNAwas ligated into the linearized vector using T4-DNA ligase (MBI) in the
presence of ATP-containing reaction buffer (MBI) at 4 °C overnight, followed by ligase inactivation at
65 °C for 10 min. The ligated plasmids were transformed into competent E. coli JM 109, and
kanamycin-resistant clones were used for isolation of vector cDNA (Qiagen, Hilden, Germany), which
was eluted and stored in 10 mM Tris–HCl at pH 8.0. Control digests of the isolated plasmids were
performed with NheI and BamHI, each used at 0.25 U/mg plasmid DNA, for insert restriction, and
additionally EcoRI with a restriction within the insert was used (all, MBI) before analyzing on 1%
agarose gels by electrophoresis. Finally, sequencing using the primers “CMV-Profor” (50-aaa tgg gcg
gta ggc gtg-30) and “EGFP-Nrev” (50-cgt cgc cgt cca gct c-30) conﬁrmed the correct product (Sequi-
serve, Vaterstetten, Germany).1.3. Transfection of HCT116 cells
The human colorectal carcinoma HCT116 cell line was purchased from ATCC (Teddington, Mid-
dlesex, UK). The cells were cultured at 37 °C in a 5.0% CO2-atmosphere (Heraeus Instruments GmbH,
Osterode, Germany) in RPMI-1640 medium (Biowhittaker™) supplemented with 10% fetal calf serum
(Lonza, Verviers, Belgium). Transfection with pEGFP-N1 and phCL-EGFP was performed using X-treme
GENE HP DNA transfection reagent (Roche Diagnostics, Mannheim, Germany) following the manu-
facturer's protocol.
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Cell proliferation rates and metabolic activity levels of transfected HCT116 cells were examined by
a colorimetric assay in which the yellow 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide (MTT) is reduced to form purple formazan crystals by intracellular NAD(P)H-oxidoreductase.
The assays were performed in duplicates and repeated at least twice as previously described [8], and
the reaction product was quantiﬁed at 595 nm with a Tecan GENios Reader (Tecan Deutschland
GmbH, Crailsheim, Germany).1.5. Lysate preparation, SDS-PAGE, and immunoblotting
Transfected HCT116 cells were used 24 h post-transfection, and whole cell lysates were prepared
in PBS containing 0.2% Triton X-100 as described before [9], normalized to equal amounts of protein
and loaded onto 12.5% SDS-polyacrylamide gels (GE Healthcare, 80-1255-53) along with a PAGE ruler
pre-stained protein ladder (Fermentas). After transfer onto nitrocellulose, blots were incubated with
goat anti-human cathepsin L (1:500, Neuromics GT15049) and rabbit anti-human β-tubulin (1:1000,
Abcam 6046-100) with HRP-coupled secondary antibodies used for subsequent visualization by
enhanced chemi-luminescence onto CL-XPosure ﬁlm (Pierce, through Perbio Science Europe, Bonn,
Germany).2. Results
Cathepsin L has been shown to be mis-trafﬁcked in HCT116 cells and to enter the nucleus as an
unexpected scene of potential action [1]. Nuclear cathepsin L is suggested to involve in regulation of
cell cycle progression of HCT116 cells by accelerating S phase [1]. Moreover, the vector phCL-EGFP
coding for EGFP-tagged cathepsin L was expressed in HCT116 cells and sorted to the nucleus [1,
Fig. 7D0].
2.1. Construction of the phCL-EGFP vector
Vector construction was performed upon cloning of human cathepsin L from non-tumorigenic
HaCaT keratinocytes and cDNA was inserted into the pEGFP-N1 vector (Clontech, Heidelberg, Ger-
many), resulting in the fusion of sequences coding for cathepsin L and eGFP in phCL-EGFP. The cloning
strategy (Fig. 1) involved removal of the stop-codon at the 30-end of cathepsin L cDNA, and introduced
restriction sites for NheI and BamHI at the 50- and 30-ends, respectively, to ensure that the complete
coding sequence was ampliﬁed. Removal of the stop-codon by BamHI digestion permitted further
transcription once the gene was ligated in-frame into the suitable vector pEGFP-N1 to obtain mRNA
coding for a fusion construct of cathepsin L and the marker protein enhanced GFP.
Transformed E. coli colonies with the cathepsin L sequence inserted into the EGFP-encoding vector
were cultivated in kanamycin-containing LB medium, and plasmids were harvested from this broth ofFig. 1. Scheme of speciﬁc ampliﬁcation primers and expected amplicon. Forward and reverse primers for gene-speciﬁc
ampliﬁcation of cathepsin L are indicated in red and their amplicon is highlighted in green. Cleavage sites of NheI and BamHI
are indicated by arrows. Numbers denote the length of the gene.
Fig. 2. Agarose gel of control digest of phCL-EGFP. Agarose gel of harvested plasmid phCL-EGFP from three different clones after
colony PCR and digestion with NheI, BamHI, and EcoRI is depicted. The expected fragments for cathepsin L-inserts and line-
arized vector with a length of 4700 bp, 760 bp, and 259 bp were detected after digest (arrowheads).
Fig. 3. Partial sequence of phCL-EGFP. Nucleotide sequence of insert region of phCL-EGFP as revealed by up- and down-stream
sequencing reactions is depicted. The cathepsin L-coding sequence is highlighted in light green, sequences of the surrounding
vector are labeled in red, start-codons ATG of cathepsin L and EGFP, respectively, are underlined, primers are marked in dark
green, the cleavage site of NheI is shown in black, the restriction site of BamHI is marked in pink, and the EcoRI site in grey,
while the spacer sequence between cathepsin L and EGFP is color-coded in dark blue.
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digested with NheI and BamHI to gain the insert, and additionally with EcoRI, which cleaves once
within the cathepsin L sequence. Therefore, after digest of cathepsin L-EGFP-containing plasmids,
fragments with a length of 4700 bp, 760 bp, and 259 bp were expected. The preparations were
analyzed by agarose gel electrophoresis, and three bands of the expected size were observed in the
digests of phCL-EGFP (Fig. 2).
Next, the plasmid phCL-EGFP was sequenced from downstream (starting 50) and upstream
(starting 30) in the vector (Fig. 3). Alignment of this cDNA sequence with the reported human
cathepsin L sequence (preprocathepsin L precursor, Homo sapiens, accession number GenBank
AAA66974.1) revealed 100% identity, conﬁrming that cathepsin L-coding cDNA was inserted into the
pEGFP-N1 vector as shown in the vector map of phCL-EGFP (Fig. 4).
Fig. 4. Vector map of phCL-EGFP. Scheme of the 5.7-kb-vector phCL-EGFP coding for full-length cathepsin L-EGFP chimeric
protein is depicted. Note that cathepsin L was cloned into the multiple cloning site (MCS) of the pEGFP-N1 vector (Clontech)
using NheI and BamHI as indicated. Additionally the restriction site for EcoRI within the cDNA sequence that was used for
control digests is marked (arrow). Numbers denote the size of full-length cathepsin L-coding cDNA and that of the expected
fragments after control digest.
Fig. 5. Effects of cathepsin L-EGFP expression on proliferation and metabolic activity of HCT116 cells. Quantitative analyses of
cell numbers and metabolic activities by MTT assays were performed with non-transfected HCT116 cells in comparison to cells
analyzed 24 h after transfection with pEGFP and phCL-EGFP, as indicated. Values are given as means7standard deviations of at
least two independent experiments.
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Sub-conﬂuent cultures of HCT116 cells were transiently transfected with phCL-EGFP yielding
expression of full-length cathepsin L, which was co-localized with endogenous cathepsin L and also
reached the nuclei (see Fig. 7D0 in [1]). In addition, MTT assays were performed with non-transfected,
pEGFP-N1-, and phCL-EGFP-transfected HCT116 cells after 24 h. Data revealed that proliferation rates
were not altered upon expression of enhanced GFP alone, while the MTT conversion rates were
increased in HCT116 cells expressing hCL-EGFP chimeras (Fig. 5), although this increase did not reach
signiﬁcance over non-transfected controls.2.3. Molecular forms of cathepsin L-EGFP chimeras translated in HCT116 cells
To identify the molecular forms of the cathepsin L-EGFP chimeras translated in HCT116 cells,
immunoblotting was performed with whole cell Iysates of non-transfected cultures and with those
expressing pEGFP-N1 or phCL-EGFP, respectively. The expected molecular forms of cathepsin L were
Fig. 6. Molecular forms and integrity of transiently expressed cathepsin L-EGFP chimeras in HCT116 cells. Immunoblot analyses
were conducted with whole cell lysates of HCT116 cells transiently expressing pEGFP-N1 and phCL-EGFP as indicated, in
comparison to non-transfected controls. Visualization of bands immunoreactive with cathepsin L-speciﬁc antibodies (A) was
performed by enhanced chemi-luminescence. Note that the chimeric protein CL-EGFP was detectable at approx. 65 kDa as
expected for the intact protein. In addition, all expected molecular forms of cathepsin L were detected with anti-cathepsin
L-speciﬁc antibodies (pro, SC, and HC). ß-Tubulin was used as a loading control (B). Molecular mass markers are indicated in the
left margins.
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two-chain form of the protease. Lysates of phCL-EGFP-transfected HCT116 cells featured an additional
band at 65 kDa that was recognized by cathepsin L-speciﬁc antibodies (Fig. 6), and which was absent
from non-transfected cells or those transfected with the empty vector pEGFP-N1. The data indicates
that the band at 65 kDa is representative of the hCL-EGFP chimeric protein which was stable for 24 h
in HCT116 cells because no degradation bands could be observed in immunoblots with cathepsin L-
speciﬁc antibodies (Fig. 6).Acknowledgments
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